1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 4: 
Cochlear hydrops according to Nakashima grading
SE (%) (95% CI)SP (%) (95% CI)PPV (%) (95% CI)NPV (%) (95% CI)
Symptomatic MD vs asymptomatic MD74 (53–88)78 (56–92)80 (59–92)72 (50–87)
Symptomatic MD vs healthy74 (53–88)96 (77–100)95 (74–100)77 (57–89)
Symptomatic MD vs SSHL74 (53–88)83 (62–95)83 (62–95)74 (53–88)
Symptomatic MD vs other74 (53–88)86 (75–93)67 (47–82)90 (79–95)
  • Note:—SE indicates sensitivity; SP, specificity.